inotuzumab_ozogamicin  - Drug Details
📊 Estimates inotuzumab_ozogamicin  Dialyzability By Different_Modalities

inotuzumab_ozogamicin 

Complete Drug Information

Drug Name
inotuzumab_ozogamicin 
Trade Names
Besponsa
Pregnancy Category
AU: D
Routes of Administration
Intravenous
Protein Binding
97% (cytotoxic agent)%
Elimination
12.3 days
Formula
C6518H10002N1738O2036S42
Molar Mass
146634.36
Volume of Distribution
C6518H10002N1738O2036S42

🤰 Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.